Linde Plc

  • Market Cap: Large Cap
  • Industry: Specialty Chemicals
  • ISIN: IE000S9YS762
USD
403.73
-5.06 (-1.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.16 M

Shareholding (Mar 2025)

FII

24.58%

Held by 591 FIIs

DII

38.25%

Held by 82 DIIs

Promoter

0.54%

How big is Linde Plc?

22-Jun-2025

As of Jun 18, Linde Plc has a market capitalization of $245.19 billion, with recent net sales of $33.02 billion and a net profit of $6.78 billion.

Market Cap: As of Jun 18, Linde Plc has a market capitalization of 245,185.15 million, classifying it as a Large Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Linde Plc reported net sales of 33,017.00 million and a net profit of 6,779.00 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 38,092.00 million and total assets of 80,147.00 million.

Read More

What does Linde Plc do?

22-Jun-2025

Linde Plc is an industrial gases and engineering company in the specialty chemicals sector, with a market cap of approximately $245 billion. As of March 2025, it reported net sales of $8.1 billion and a net profit of $1.7 billion.

Overview: <BR>Linde Plc is an industrial gases and engineering company operating in the specialty chemicals industry, with a market capitalization in the large-cap bracket.<BR><BR>Financial Snapshot: <BR>Net Sales: 8,112 Million (Quarterly Results - Mar 2025) <BR>Net Profit: 1,707 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 245,185.15 Million (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 36.00 <BR>Dividend Yield: 0.01% <BR>Debt Equity: 0.49 <BR>Return on Equity: 18.21% <BR>Price to Book: 6.45<BR><BR>Contact Details: <BR>Address: The Priestley Centre, 10 Priestley Road, GUILDFORD None: GU2 7XY <BR>Tel: ['44 1483 242200', '1 203 8372213'] <BR>Website: https://www.lindeplc.com/en

Read More

Should I buy, sell or hold Linde Plc?

22-Jun-2025

Who are in the management team of Linde Plc?

22-Jun-2025

As of March 2022, the management team of Linde Plc includes Prof. Dr. Wolfgang Reitzle (Independent Chairman), Mr. Stephen Angel (CEO), and several Independent Directors: Prof. Dr. Ann-Kristin Achleitner, Dr. Clemens Boersig, Dr. Nance Dicciani, Dr. Thomas Enders, and Mr. Franz Fehrenbach. They are responsible for the company's strategic direction and governance.

As of March 2022, the management team of Linde Plc includes the following members:<BR><BR>- Prof. Dr. Wolfgang Reitzle, who serves as the Independent Chairman of the Board.<BR>- Mr. Stephen Angel, who is the Chief Executive Officer and a Director.<BR>- Prof. Dr. Ann-Kristin Achleitner, serving as an Independent Director.<BR>- Dr. Clemens Boersig, also an Independent Director.<BR>- Dr. Nance Dicciani, who is an Independent Director.<BR>- Dr. Thomas Enders, serving as an Independent Director.<BR>- Mr. Franz Fehrenbach, who is an Independent Director. <BR><BR>This team is responsible for guiding the company's strategic direction and governance.

Read More

Is Linde Plc technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Linde Plc's technical trend is neutral with mixed signals, showing mild bearishness on weekly and monthly indicators, underperforming the S&P 500 recently but outperforming year-to-date, suggesting a cautious outlook.

As of 3 October 2025, the technical trend for Linde Plc has changed from mildly bullish to sideways. The current stance is neutral, with a mildly bearish indication from the weekly and monthly MACD and KST. The Bollinger Bands show a mixed signal, being mildly bearish on the weekly and mildly bullish on the monthly. Daily moving averages are mildly bullish, while Dow Theory indicates a mildly bullish monthly trend but no trend on the weekly. <BR><BR>In terms of performance, Linde has underperformed the S&P 500 over the past week and month, with returns of -1.67% and -0.21% compared to 1.09% and 4.15% for the index, respectively. However, it has outperformed the S&P 500 year-to-date with an 11.91% return against 14.18%. Overall, the technical indicators suggest a cautious outlook.

Read More

Is Linde Plc overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Linde Plc is considered undervalued with an attractive valuation grade, reflected in its lower P/E ratio of 36 compared to peers, strong long-term growth potential, and competitive EV to EBITDA ratio, despite recent underperformance against the S&P 500.

As of 17 October 2025, the valuation grade for Linde Plc has moved from expensive to attractive, indicating a shift towards being undervalued. The company is currently considered attractive based on its P/E ratio of 36, which is lower than the peer average of 42.93 for Ecolab, Inc., and its EV to EBITDA ratio of 21.57, which is also competitive against Ecolab's 28.89. Additionally, Linde's PEG ratio stands at 3.26, suggesting that while growth expectations are high, the valuation may still be justified relative to its peers.<BR><BR>In comparison to its peers, Linde Plc shows a more favorable valuation profile, particularly when contrasted with Air Products & Chemicals, Inc., which has a significantly lower P/E ratio of 15.89. Despite recent underperformance against the S&P 500, with a 1-year return of -7.24% compared to the index's 14.08%, Linde's long-term performance over 5 years at 93.45% indicates strong growth potential. Overall, Linde Plc appears to be undervalued in the current market context.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.31 times

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 4.10% and Operating profit at 20.78%

 
3

Flat results in Jun 25

4

With ROCE of 15.50%, it has a fair valuation with a 4.77 Enterprise value to Capital Employed

5

High Institutional Holdings at 86.79%

6

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 251,628 Million (Large Cap)

stock-summary
P/E

36.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.55

stock-summary
Return on Equity

18.31%

stock-summary
Price to Book

6.53

Revenue and Profits:
Net Sales:
8,495 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,806 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.42%
0%
-14.42%
6 Months
-14.43%
0%
-14.43%
1 Year
-11.87%
0%
-11.87%
2 Years
-1.94%
0%
-1.94%
3 Years
19.68%
0%
19.68%
4 Years
25.89%
0%
25.89%
5 Years
63.98%
0%
63.98%

Linde Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.10%
EBIT Growth (5y)
20.78%
EBIT to Interest (avg)
43.26
Debt to EBITDA (avg)
1.31
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.55
Tax Ratio
23.65%
Dividend Payout Ratio
40.83%
Pledged Shares
0
Institutional Holding
86.79%
ROCE (avg)
12.61%
ROE (avg)
13.35%
Valuation key factors
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
6.61
EV to EBIT
30.76
EV to EBITDA
21.57
EV to Capital Employed
4.77
EV to Sales
8.18
PEG Ratio
3.26
Dividend Yield
0.01%
ROCE (Latest)
15.50%
ROE (Latest)
18.21%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 230 Schemes (36.58%)

Foreign Institutions

Held by 591 Foreign Institutions (24.58%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 4.72% vs -2.05% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.80% vs -3.50% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,495.00",
          "val2": "8,112.00",
          "chgp": "4.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,281.00",
          "val2": "3,131.00",
          "chgp": "4.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "31.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-24.00",
          "val2": "-143.00",
          "chgp": "83.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,806.00",
          "val2": "1,707.00",
          "chgp": "5.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "275.30%",
          "val2": "273.80%",
          "chgp": "0.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.46% vs -1.53% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.25% vs 48.12% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33,005.00",
          "val2": "32,854.00",
          "chgp": "0.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12,375.00",
          "val2": "11,921.00",
          "chgp": "3.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "572.00",
          "val2": "488.00",
          "chgp": "17.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-73.00",
          "val2": "38.00",
          "chgp": "-292.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6,737.00",
          "val2": "6,341.00",
          "chgp": "6.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "260.40%",
          "val2": "246.70%",
          "chgp": "1.37%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
8,495.00
8,112.00
4.72%
Operating Profit (PBDIT) excl Other Income
3,281.00
3,131.00
4.79%
Interest
31.00
0.00
Exceptional Items
-24.00
-143.00
83.22%
Consolidate Net Profit
1,806.00
1,707.00
5.80%
Operating Profit Margin (Excl OI)
275.30%
273.80%
0.15%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 4.72% vs -2.05% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 5.80% vs -3.50% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
33,005.00
32,854.00
0.46%
Operating Profit (PBDIT) excl Other Income
12,375.00
11,921.00
3.81%
Interest
572.00
488.00
17.21%
Exceptional Items
-73.00
38.00
-292.11%
Consolidate Net Profit
6,737.00
6,341.00
6.25%
Operating Profit Margin (Excl OI)
260.40%
246.70%
1.37%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 0.46% vs -1.53% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 6.25% vs 48.12% in Dec 2023

stock-summaryCompany CV
About Linde Plc stock-summary
stock-summary
Linde Plc
Specialty Chemicals
Linde plc is an industrial gases and engineering company that operates through its subsidiaries. The Company provides atmospheric gases (oxygen, nitrogen, argon and rare gases) and process gases (carbon dioxide, helium, hydrogen, electronic gases, specialty gases and acetylene). It designs, engineers and builds equipment that produces industrial gases primarily for internal use. It also offers gaseous medication and related medical products and devices for patients and medical staff. The Company serves the customers in various industries, including healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals and water treatment.
Company Coordinates stock-summary
Company Details
The Priestley Centre, 10 Priestley Road , GUILDFORD None : GU2 7XY
stock-summary
Tel: 44 1483 2422001 203 8372213
stock-summary
Registrar Details